| Serial Number | 88977773 |
| Word Mark | PAPA & BARKLEY |
| Filing Date | Monday, February 25, 2019 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Thursday, October 13, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Mentholated ointment for medical use, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Medicated skin oils, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Topical analgesics, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Analgesic balm, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Medicated skin creams and lotions, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; medicated skin care preparations, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; medicated herbal topical creams, gels, skin sprays, balms, liniment and ointments, all the foregoing for the relief of pain, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Topical gel for medical and therapeutic treatment of minor aches and pains of muscles and joints, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Herbal tinctures for medical purposes, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Orally-ingestible herbal tinctures for medicinal purposes in the nature of nutritional and dietary supplements, all of the foregoing containing only naturally-occurring levels of CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Medicated oral spray for pain, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Pharmaceutical, medicinal, medicated herbal, medicated botanical, and medicated preparations in the form of salves, concentrates, pastes, extracts, tinctures, and mucous membrane doses, for use in connection with pain, muscle tension, muscle spasms, and gastrointestinal illness, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient, all of the foregoing containing no cannabis and no cannabinoids, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act; Muscle soaks, all of the foregoing containing CBD derived from cannabis with a delta-9 THC concentration of not more than 0.3% on a dry weight basis, all the foregoing not including any products noncompliant with the U.S. Food Drug and Cosmetic Act |
| Pseudo Mark | PAPA AND BARKLEY |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 15, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Egg Rock Holdings, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Glendale, CA 91206 |
| Event Date | Event Description |
| Thursday, October 13, 2022 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Thursday, October 13, 2022 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Thursday, October 13, 2022 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Tuesday, March 22, 2022 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED |
| Tuesday, March 22, 2022 | SUBSEQUENT FINAL EMAILED |
| Tuesday, March 22, 2022 | SUBSEQUENT FINAL REFUSAL WRITTEN |
| Tuesday, September 28, 2021 | DIVISIONAL PROCESSING COMPLETE |
| Friday, September 24, 2021 | DIVISIONAL REQUEST RECEIVED |
| Friday, September 24, 2021 | TEAS REQUEST TO DIVIDE RECEIVED |
| Saturday, June 5, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, June 4, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, June 4, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, March 10, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, March 10, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, March 10, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, December 7, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, December 7, 2020 | NON-FINAL ACTION E-MAILED |
| Monday, December 7, 2020 | NON-FINAL ACTION WRITTEN |
| Saturday, June 13, 2020 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Saturday, June 13, 2020 | FINAL REFUSAL E-MAILED |
| Saturday, June 13, 2020 | FINAL REFUSAL WRITTEN |
| Monday, May 11, 2020 | DIVISIONAL PROCESSING COMPLETE |
| Wednesday, April 29, 2020 | DIVISIONAL REQUEST RECEIVED |
| Monday, May 11, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, May 11, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 29, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, May 4, 2020 | ASSIGNED TO LIE |
| Wednesday, April 29, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, April 29, 2020 | TEAS REQUEST TO DIVIDE RECEIVED |
| Tuesday, October 29, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, October 29, 2019 | NON-FINAL ACTION E-MAILED |
| Tuesday, October 29, 2019 | NON-FINAL ACTION WRITTEN |
| Monday, October 28, 2019 | ASSIGNED TO EXAMINER |
| Monday, May 6, 2019 | ASSIGNED TO EXAMINER |
| Monday, May 6, 2019 | ASSIGNED TO EXAMINER |
| Friday, March 15, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, February 28, 2019 | NEW APPLICATION ENTERED |